Showing 25–36 of 108 results

  • Diglifloz 5\1000mg Plus 30 Tablets

    Diglifloz 5\1000mg Plus 30 Tablets

    0 out of 5
    EGP183

    Medication Name: Diglifloz 5/1000mg Plus 30 Tablets Active Ingredients: Dapagliflozin 5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination of SGLT2 inhibitor and biguanide antidiabetic agent Indication:Used in adults with type 2 diabetes mellitus to improve glycemic control when treatment with both dapagliflozin and metformin is appropriate, as an adjunct to diet and exercise. Dosage:One tablet…

  • Empacoza 10mg 30tablets

    Empacoza 10mg 30tablets

    0 out of 5
    EGP240

    Medication Name: Empacoza 10 mg 30 Tablets Active Ingredient:Empagliflozin 10 mg Pharmacological Class:SGLT2 inhibitor (Sodium–Glucose Cotransporter-2 inhibitor) Indications:Used in adults with type 2 diabetes mellitus to: Improve glycemic control as monotherapy or in combination with other antidiabetic drugs. Reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. May…

  • Empacoza 25mg 30tablets

    Empacoza 25mg 30tablets

    0 out of 5
    EGP240

    Medication Name: Empacoza 25 mg 30 Tablets Active Ingredient:Empagliflozin 25 mg Pharmacological Class:SGLT2 inhibitor (Sodium–Glucose Cotransporter-2 inhibitor) Indications:Used in adults with type 2 diabetes mellitus to: Improve glycemic control as monotherapy or in combination with other antidiabetic agents. Reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. May…

  • Empacoza Plus 10\5mg 30tablets

    Empacoza Plus 10\5mg 30tablets

    0 out of 5
    EGP357

    Medication Name: Empacoza Plus 10/5 mg 30 Tablets Active Ingredients: Empagliflozin 10 mg Linagliptin 5 mg Pharmacological Class:Oral antidiabetic combination (SGLT2 inhibitor + DPP-4 inhibitor) Indications:Used in adults with type 2 diabetes mellitus to improve glycemic control when diet, exercise, and/or monotherapy with either component alone is insufficient. Dosage Form:Film-coated tablets Administration: Taken orally once…

  • Empacoza Plus 25\5mg 30tablets

    Empacoza Plus 25\5mg 30tablets

    0 out of 5
    EGP357

    Medication Name: Empacoza Plus 25/5 mg 30 Tablets Active Ingredients: Empagliflozin 25 mg Linagliptin 5 mg Pharmacological Class:Oral antidiabetic combination (SGLT2 inhibitor + DPP-4 inhibitor) Indications:For the management of type 2 diabetes mellitus in adults to improve glycemic control when diet, exercise, and/or monotherapy with either component alone is inadequate. Dosage Form:Film-coated tablets Administration: Taken…

  • Empacoza Trio 10\5\1000mg 30tablets

    Empacoza Trio 10\5\1000mg 30tablets

    0 out of 5
    EGP396

    Medication Name: Empacoza Trio 10/5/1000 mg 30 Tablets Active Ingredients: Empagliflozin 10 mg Linagliptin 5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination oral antidiabetic agent (SGLT2 inhibitor + DPP-4 inhibitor + Biguanide) Indications:For the management of type 2 diabetes mellitus in adults to improve glycemic control when diet, exercise, and other antidiabetic medications are insufficient….

  • Empacoza Trio 25\5\1000mg 30tablets

    Empacoza Trio 25\5\1000mg 30tablets

    0 out of 5
    EGP396

    Medication Name: Empacoza Trio 25/5/1000 mg 30 Tablets Active Ingredients: Empagliflozin 25 mg Linagliptin 5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination oral antidiabetic agent (SGLT2 inhibitor + DPP-4 inhibitor + Biguanide) Indications:Used for the management of type 2 diabetes mellitus in adults to improve glycemic control when diet, exercise, and other single agents are…

  • Forxiga 10mg 28 Tablets

    Forxiga 10mg 28 Tablets

    0 out of 5
    EGP602

    Medication Name: Forxiga 10mg 28 Tablets Active Ingredient:Dapagliflozin 10 mg Pharmacological Class:SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Indication:Used for the treatment of: Type 2 diabetes mellitus to improve glycemic control as monotherapy or in combination with other antidiabetic drugs. Heart failure with reduced ejection fraction. Chronic kidney disease to reduce the risk of progression, hospitalization, or…

  • Forxiga 5mg 28 Tablets

    Forxiga 5mg 28 Tablets

    0 out of 5
    EGP602

    Medication Name: Forxiga 5mg 28 Tablets Active Ingredient:Dapagliflozin 5 mg Pharmacological Class:SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Indication:Used for the treatment of: Type 2 diabetes mellitus to improve blood glucose control as monotherapy or in combination with other antidiabetic agents. May be considered in certain cases of heart failure or chronic kidney disease under medical supervision….

  • Galvus Met 50\1000mg 30tablets

    Galvus Met 50\1000mg 30tablets

    0 out of 5
    EGP315

    Medication Name: Galvus Met 50/1000 mg 30 Tablets Active Ingredients:Vildagliptin 50 mgMetformin Hydrochloride 1000 mg Pharmacological Class:Dipeptidyl Peptidase-4 (DPP-4) inhibitor + Biguanide combination Indication:Used to improve blood glucose control in adults with type 2 diabetes mellitus when diet, exercise, and either vildagliptin or metformin alone do not provide adequate control. Dosage:Typically one tablet taken twice…

  • Galvus Met 50\500mg 30tablets

    Galvus Met 50\500mg 30tablets

    0 out of 5
    EGP258

    Medication Name: Galvus Met 50/500 mg 30 Tablets Active Ingredients:Vildagliptin 50 mgMetformin Hydrochloride 500 mg Pharmacological Class:Dipeptidyl Peptidase-4 (DPP-4) inhibitor + Biguanide combination Indication:Used to control blood glucose levels in adults with type 2 diabetes mellitus when diet, exercise, and either vildagliptin or metformin alone are inadequate. Dosage:Typically one tablet taken twice daily (morning and…

  • Galvus Met 50\850mg 30tablets

    Galvus Met 50\850mg 30tablets

    0 out of 5
    EGP309

    Medication Name: Galvus Met 50/850 mg 30 Tablets Active Ingredients:Vildagliptin 50 mgMetformin Hydrochloride 850 mg Pharmacological Class:Dipeptidyl Peptidase-4 (DPP-4) inhibitor + Biguanide combination Indication:Used in adults with type 2 diabetes mellitus to improve glycemic control when diet, exercise, and either vildagliptin or metformin alone are insufficient. Dosage:Usually one tablet taken twice daily (morning and evening)…

End of content

End of content